Expanded Access to Opioid Abuse Treatment Act of 2017

Expanded Access to Opioid Abuse Treatment Act of 2017

This bill amends the Controlled Substances Act to allow a pharmacist who meets specified criteria to be a qualifying practitioner who may administer, dispense, or prescribe narcotic drugs for maintenance or detoxification treatment in an office-based opioid treatment program.

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[H.R. 3991 Introduced in House (IH)]

<DOC>






115th CONGRESS
  1st Session
                                H. R. 3991

 To amend section 303(g)(2) of the Controlled Substances Act to allow 
   certain pharmacists to dispense narcotic drugs for maintenance or 
  detoxification treatment pursuant to the same waiver provisions as 
  apply with respect to nurse practitioners and physician assistants.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                            October 6, 2017

Ms. Michelle Lujan Grisham of New Mexico introduced the following bill; 
  which was referred to the Committee on Energy and Commerce, and in 
    addition to the Committee on the Judiciary, for a period to be 
subsequently determined by the Speaker, in each case for consideration 
  of such provisions as fall within the jurisdiction of the committee 
                               concerned

_______________________________________________________________________

                                 A BILL


 
 To amend section 303(g)(2) of the Controlled Substances Act to allow 
   certain pharmacists to dispense narcotic drugs for maintenance or 
  detoxification treatment pursuant to the same waiver provisions as 
  apply with respect to nurse practitioners and physician assistants.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Expanded Access to Opioid Abuse 
Treatment Act of 2017''.

SEC. 2. ELIGIBILITY OF CERTAIN PHARMACISTS FOR WAIVERS FOR DISPENSING 
              NARCOTIC DRUGS FOR MAINTENANCE OR DETOXIFICATION 
              TREATMENT.

    Section 303(g)(2)(G)(iv) of the Controlled Substances Act (21 
U.S.C. 823(g)(2)(G)(iv)) is amended--
            (1) by striking ``nurse practitioner or physician 
        assistant'' each place it appears and inserting ``nurse 
        practitioner, physician assistant, or pharmacist''; and
            (2) in subclause (II)(aa), by inserting ``the American 
        Pharmacists Association,'' before ``or any other 
        organization''.
                                 <all>